Ghost Tree Capital as of June 30, 2015
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 65 positions in its portfolio as reported in the June 2015 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Flamel Technologies Sa Sponsored Adr | 4.2 | $12M | 575k | 21.19 | |
Biogen Idec (BIIB) | 4.2 | $12M | 30k | 403.93 | |
NuVasive | 3.8 | $11M | 235k | 47.38 | |
Alnylam Pharmaceuticals (ALNY) | 3.7 | $11M | 90k | 119.87 | |
Five Prime Therapeutics | 3.6 | $11M | 425k | 24.84 | |
Intuitive Surgical Com New (ISRG) | 3.3 | $9.7M | 20k | 484.50 | |
Gw Pharmaceuticals Ads | 3.2 | $9.2M | 75k | 122.84 | |
Alexion Pharmaceuticals | 3.1 | $9.0M | 50k | 180.78 | |
Portola Pharmaceuticals | 2.7 | $7.7M | 170k | 45.55 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 2.6 | $7.4M | 60k | 123.48 | |
Horizon Pharma SHS | 2.4 | $6.9M | 200k | 34.74 | |
GenMark Diagnostics | 2.3 | $6.8M | 750k | 9.06 | |
Sage Therapeutics (SAGE) | 2.3 | $6.5M | 89k | 73.01 | |
Nanostring Technologies (NSTGQ) | 2.1 | $6.2M | 400k | 15.42 | |
Esperion Therapeutics (ESPR) | 2.1 | $6.1M | 75k | 81.76 | |
Cepheid | 2.1 | $6.1M | 100k | 61.15 | |
CIGNA Corporation | 2.1 | $6.1M | 38k | 162.00 | |
Epizyme | 2.1 | $6.0M | 250k | 24.00 | |
Neurocrine Biosciences (NBIX) | 2.0 | $5.9M | 123k | 47.76 | |
Amicus Therapeutics (FOLD) | 1.8 | $5.3M | 375k | 14.15 | |
Atara Biotherapeutics (ATRA) | 1.8 | $5.3M | 100k | 52.76 | |
Dex (DXCM) | 1.8 | $5.2M | 65k | 79.98 | |
Aetna | 1.8 | $5.1M | 40k | 127.45 | |
Anacor Pharmaceuticals In | 1.7 | $5.0M | 65k | 77.43 | |
Uniqure Nv SHS (QURE) | 1.7 | $5.0M | 185k | 27.00 | |
Endochoice Hldgs | 1.7 | $4.9M | 300k | 16.35 | |
Ptc Therapeutics I (PTCT) | 1.7 | $4.8M | 100k | 48.13 | |
Cellectis S A Sponsored Ads (CLLS) | 1.6 | $4.5M | 125k | 36.08 | |
Vanda Pharmaceuticals (VNDA) | 1.5 | $4.4M | 350k | 12.69 | |
Zeltiq Aesthetics | 1.5 | $4.4M | 150k | 29.47 | |
Cynapsus Therapeutics Com Par No Par | 1.5 | $4.3M | 263k | 16.29 | |
Ironwood Pharmaceuticals Com Cl A (IRWD) | 1.5 | $4.2M | 350k | 12.06 | |
Vitae Pharmaceuticals | 1.4 | $4.2M | 289k | 14.40 | |
Wright Medical | 1.4 | $3.9M | 150k | 26.26 | |
Alcobra SHS | 1.4 | $3.9M | 600k | 6.54 | |
Dbv Technologies S A Sponsored Adr (DBVT) | 1.3 | $3.9M | 75k | 51.87 | |
Sunesis Pharmaceuticals Com New | 1.3 | $3.8M | 1.3M | 3.01 | |
Genocea Biosciences | 1.3 | $3.7M | 270k | 13.73 | |
Assembly Biosciences | 1.2 | $3.4M | 175k | 19.26 | |
Anthem (ELV) | 1.1 | $3.3M | 20k | 164.15 | |
BioDelivery Sciences International | 1.1 | $3.2M | 406k | 7.96 | |
Rockwell Medical Technologies Call Option | 1.1 | $3.2M | 200k | 16.12 | |
Kempharm | 1.1 | $3.2M | 175k | 18.37 | |
Lion Biotechnologies | 1.1 | $3.2M | 350k | 9.17 | |
Therapeuticsmd | 1.1 | $3.1M | 400k | 7.86 | |
Axovant Sciences | 1.0 | $2.8M | 135k | 20.38 | |
Avalanche Biotechnologies In | 0.9 | $2.7M | 165k | 16.27 | |
Foamix Pharmaceuticals SHS | 0.9 | $2.6M | 250k | 10.25 | |
Puma Biotechnology (PBYI) | 0.7 | $2.0M | 18k | 116.74 | |
Tonix Pharmaceuticals Hldg C Com New | 0.6 | $1.8M | 203k | 8.97 | |
Radius Health Com New | 0.6 | $1.7M | 25k | 67.72 | |
Versartis | 0.5 | $1.5M | 100k | 15.22 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.5 | $1.4M | 77k | 18.33 | |
Ascendis Pharma A S Sponsored Adr (ASND) | 0.4 | $1.1M | 64k | 17.68 | |
Unilife US | 0.3 | $968k | 450k | 2.15 | |
Veracyte (VCYT) | 0.3 | $873k | 78k | 11.14 | |
Nivalis Therapeutics | 0.3 | $758k | 50k | 15.16 | |
BioCryst Pharmaceuticals (BCRX) | 0.2 | $672k | 45k | 14.93 | |
Kindred Biosciences | 0.2 | $638k | 94k | 6.82 | |
Biolase Technology | 0.2 | $522k | 300k | 1.74 | |
XOMA CORP Common equity shares | 0.2 | $485k | 125k | 3.88 | |
Ocera Therapeutics | 0.2 | $475k | 125k | 3.80 | |
Glaukos (GKOS) | 0.2 | $435k | 15k | 29.00 | |
Xenon Pharmaceuticals (XENE) | 0.1 | $432k | 38k | 11.52 | |
Neothetics, Inc. Cmn | 0.1 | $387k | 43k | 9.00 |